Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Key Players and Competitive Insights The GLP-1 drug market is currently characterized by intense competition and rapid growth, driven by increasing prevalence of diabetes and obesity worldwide
P = 0.72)
The role of these enzymes in tendon pathology is unknown, and further work is required to identify novel and specific molecular targets for therapy
[7] The company's primary products are tirzepatide (Mounjaro and Zepbound) for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea (56% of 2025 revenues)
EV: Conceived the study, participated in its design and coordination and helped to draft the manuscript
US$ 29.97
US$ 24.60
US$ 24.71
US$ 27.62
US$ 26.66
US$ 23.98
US$ 25.26
US$ 27.20
